Textbook of Psychiatric Epidemiology / Edition 3

Hardcover (Print)
Used and New from Other Sellers
Used and New from Other Sellers
from $179.40
Usually ships in 1-2 business days
(Save 35%)
Other sellers (Hardcover)
  • All (8) from $179.40   
  • New (6) from $179.99   
  • Used (2) from $179.40   


The new edition of this critically praised textbook continues to provide the most comprehensive overview of the concepts, methods, and research advances in the field; particularly the application of molecular genomics and of neuroimaging. It has been revised and enhanced to capitalize on the strengths of the first and second editions while keeping it up-to-date with the field of psychiatry and epidemiology. This comprehensive publication now includes chapters on experimental epidemiology, gene-environment interactions, the use of case registries, eating disorders, suicide, childhood disorders and immigrant populations, and the epidemiology of a number of childhood disorders. As in the first and second editions, the objective is to provide a comprehensive, easy to understand overview of research methods for the non-specialist. The book is ideal for students of psychiatric epidemiology, psychiatric residents, general psychiatrists, and other mental health professionals. The book features a new editor, Peter Jones, from the University of Cambridge, who joins the successful US team of Ming Tsuang and Mauricio Tohen.

Read More Show Less

Editorial Reviews

From the Publisher
"The Textbook of Psychiatric Epidemiology is a timely, up-to-date, and comprehensive book covering all aspects of the science of epidemiology as related to psychiatric disorders. Overall, this is a well written, wel-organized book that I highly recommend to all psychiatrists and neuroscientists who are interested in the underpinning of psychiatric epidemiology." (Journal of Clinical Psychiatry, 2013)

“Overall, this book provides a thorough and understandable introduction to the field of psychiatric epidemiology, suitable for students wishing to become familiar with up-to-date applications and findings in psychiatry as they relate to public health and epidemiology.” (Doody’s, 6 April 2012)

"This 3rd edition is a welcome return for this informative textbook, which will be of interest to a wide readership through its extensive scope. It covers a range of areas relevant to epidemiology and beyond with what is now the standard format involving expert authors or teams." (Acta Psychiatrica Scandinavica, 2012)

"So I started this review process with a great deal of skepticism. However, during this process I have ended up reading about areas outside my own main research field with much interest, and chapters within my own areas with much pleasure and admiration for the contributions; and, I have found myself recommending individual chapters again and again to students and other people with whom I, during this period, have discussed specific projects. So, much to my own surprise, I end up warmly recommending this book to anyone who has a professional interest in the epidemiology of, and risk factors for psychiatric disorders, and a recurring need for a fast reference to a very comprehensive array of knowledge." Read the full review. (Acta Neuropsychiatrica, 2012)

Doody's Review Service
Reviewer: Kathryn Jackson, BS (University of Illinois at Chicago School of Public Health)
Description: This is the third edition of an overview of the concepts, methods, and research advances in the field of psychiatric epidemiology that has been revised and updated with additional chapters on recent progress in research methods and advances in specific psychiatric disorders.
Purpose: The objective is to "provide a comprehensive, easy to understand overview of research methods for the non-specialist." The first 15 chapters provide a general overview of the field of epidemiology as applied to psychiatry. The second half consists of 18 chapters dedicated to the epidemiology of specific major psychiatric disorders, child/adolescent and geriatric epidemiology, and the epidemiology of disorder in immigrant populations. The extensive list of contributors provides a global perspective, as the researchers have studied in areas all over the world. The result is an overview of the importance of the applications of psychiatric epidemiology in the field of public health.
Audience: The target audience is "students of psychiatric epidemiology, psychiatric residents, general psychiatrists, and other mental health professionals." It is most appropriate for graduate students in public health and epidemiology, as it provides an overall perspective on psychiatric disorders with an emphasis on application and importance in the field of public health. The wide range of the topics, especially in the first section, may make the book too broad for established mental health professionals, although the book does imply the necessity of understanding the epidemiology of diseases when studying treatments.
Features: The first of the book's two main parts is a general overview of epidemiology, study design and methods, the natural history of psychopathology, and psychiatric assessment. The second part provides literature reviews of the epidemiology of major psychological disorders and of those disorders in specific populations. This third edition now includes chapters on experimental epidemiology, gene-environment interactions, the use of case registries, eating disorders, suicide, psychiatric disorders in immigrant populations, and the epidemiology of several childhood disorders. Clearer distinctions between sections of the book would add clarity to the chapters for readers.
Assessment: Overall, this book provides a thorough and understandable introduction to the field of psychiatric epidemiology, suitable for students wishing to become familiar with up-to-date applications and findings in psychiatry as they relate to public health and epidemiology. Unfortunately, the high price may put it out of reach for students not specifically enrolled in a psychiatric epidemiology program.
Read More Show Less

Product Details

  • ISBN-13: 9780470694671
  • Publisher: Wiley
  • Publication date: 6/15/2011
  • Edition number: 3
  • Pages: 660
  • Sales rank: 1,206,951
  • Product dimensions: 7.70 (w) x 9.90 (h) x 1.50 (d)

Meet the Author

Dr. Ming Tsuang is Behavioral Genomics Endowed Chair andUniversity Professor, University of California and DistinguishedProfessor of Psychiatry and Director, Center for BehavioralGenomics, Department of Psychiatry, University of California, SanDiego. He also directs the Harvard Institute of PsychiatricEpidemiology and Genetics. He was Stanley Cobb Professor ofPsychiatry and Chairman, Department of Psychiatry, Harvard MedicalSchool at Massachusetts Mental Health Center, where he served assuperintendent and president of Massachusetts Mental HealthInstitute of Psychiatry. He received his M.D. degree from NationalTaiwan University and his Ph.D. in Psychiatric Genetics and Doctorof Science in Genetics Epidemiology from the University of London.He has been recognized worldwide for his research in schizophrenia,manic-depressive illness and substance abuse.
He is a member of the Institute of Medicine, National Academy ofSciences, and served on the National Advisory Mental HealthCouncil, U.S. Department of Health and Human Services. He has beenelected Fellow of the American Psychiatric Association, AmericanCollege of Psychiatrists, and British Royal Society ofPsychiatrists, Fellow and former President of the AmericanPsychopathological Association. He is a Council Member of theTaiwan National Health Research Institute, and Academician,Academia Sinica of Taiwan, the highest academic institution inTaiwan. He is currently the President of the International Societyof Psychiatric Genetics.
Dr. Tsuang is the recipient of a myriad of awards for his work,among them: the Rema Lapouse Award for Mental Health Epidemiology,the American Public Health Association; the Stanley Dean Award forResearch in Schizophrenia, the American College of Psychiatrists;the National Institute of Mental Health Merit Award; the NoyesAward for Research in Schizophrenia; the National Alliance forResearch on Schizophrenia and Depression Distinguished InvestigatorAward; and the Paul H. Hoch Award, the American PsychopathologicalAssociation. Dr. Tsuang also received the Lifetime AchievementAward from the International Society of Psychiatric Genetics, theTaiwanese-American Award for Achievement in Science andEngineering, the Gold Medal Award from the Society of BiologicalPsychiatry for pioneering contributions in the field of biologicalpsychiatry, and the Award for Research in Psychiatry, the AmericanPsychiatric Association.
He has authored or co-authored over 600 publications, includingpeer review journal papers, book chapters and books in the areas ofpsychiatric epidemiology and genetics, including major psychosesand substance abuse and spiritual health. In addition to serving onmany editorial boards of scientific journals, he is currently theSenior Editor for Neuropsychiatric Genetics, a section ofthe American Journal of Medical Genetics.

Dr. Mauricio Tohen obtained his MD degree from theNational University of Mexico. He completed a residency inPsychiatry at the University of Toronto and a Fellowship inPsychopharmacology at McLean Hospital, Harvard Medical School. Heobtained his doctorate in Epidemiology from the Harvard School ofPublic Health and an MBA from the University of Indiana. From 1988to 1997 he was the clinical Director of the Bipolar and PsychoticDisorders Program at McLean Hospital. From 1997 to 2008 he workedat Lilly Research Laboratories in Indianapolis, Indiana where hereached the most senior scientific rank of Distinguished LillyScholar. In 2009 he was appointed to the Krus endowed chair inPsychiatry at the University of Texas Health Science Centre at SanAntonio. His research has focused on the clinical epidemiology andpsychopharmacological treatments of bipolar disorder. ProfessorTohen has over 200 original publications and over 500 book chaptersand scientific abstracts. He has co-edited Mood Disorders Acrossthe Lifespan and Bipolar Psychopharmacology, and hasalso edited Comorbidity in Affective Disorders.

Professor Peter Jones is Head of the Department ofPsychiatry at the University of Cambridge. His particular clinicalinterest is in psychotic illness and asking questions about causesand treatment. His research concerns lifecourse influences on adultmental health and illness, and the interface betweenpopulation-based and biological investigation andexplanations.
He is a member of the Wellcome Trust Clinical Epidemiology ResearchBoard and the HTA Commissioning Board.

Read More Show Less

Table of Contents

List of Contributors.

1 Introduction to epidemiologic research methods (GlynLewis).

1.1 What is epidemiology?

1.2 Causation in medicine.

1.3 Causal inference.

1.4 The future for psychiatric epidemiology.

2 Analysis of categorical data: The odds ratio as a measureof association and beyond (Garrett M. Fitzmaurice andCaitlin Ravichandran).

2.1 Introduction.

2.2 Inference for a single proportion.

2.3 Analysis of 2 x 2 contingency tables.

2.4 Analysis of sets of 2 x 2 contingency tables.

2.5 Logistic regression.

2.6 Advanced topics.

2.7 Concluding remarks.

2.8 Further reading.

3 Genetic epidemiology (Stephen V. Faraone, Stephen J.Glatt and Ming T. Tsuang).

3.1 Introduction.

3.2 The chain of psychiatric genetic research.

3.3 Psychiatric genetics and psychiatric epidemiology.

4 Examining gene–environment interplay in psychiatricdisorders (Judith Allardyce and Jim van Os).

4.1 Introduction.

4.2 The process of genetic epidemiology.

4.3 Gene–environment interplay takes different forms.

4.4 Gene–environment correlation.

4.5 Gene–environment interaction.

4.6 Measurement of genotype, environmental exposure andpathological phenotype.

4.7 Models of GxE.

4.8 Which scale should we use to measure GxE?

4.9 Study designs for the detection of GxE.

4.10 Threats to the validity of epidemiological GxE studies.

4.11 Epigenetic mechanisms.

5 Reliability (Patrick E. Shrout).

5.1 Introduction.

5.2 The reliability coefficient.

5.3 Designs for estimating reliability.

5.4 Statistical remedies for low reliability.

5.5 Reliability theory and binary judgements.

5.6 Reliability statistics: General.

5.7 Other reliability statistics.

5.8 Summary and conclusions.

6 Moderators and mediators: Towards the genetic andenvironmental bases of psychiatric disorders (Helena ChmuraKraemer).

6.1 Introduction.

6.2 Current methodological barriers.

6.3 Moderation, mediation and other ways in which risk factors'work together'.

6.4 Extensions.

6.5 Beyond moderators and mediators.

7 Validity: Definitions and applications to psychiatricresearch (Jill M. Goldstein, Sara Cherkerzian and John C.Simpson).

7.1 Introduction.

7.2 Validity of a construct.

7.3 Validity of the relationships between variables.

7.4 Summary.

8 Use of register data for psychiatric epidemiology in theNordic countries (Jouko Miettunen, Jaana Suvisaari, JariHaukka and Matti Isohanni).

8.1 Introduction.

8.2 Registers for use in psychiatric research.

8.3 Register research in Denmark.

8.4 Register research in Finland.

8.5 Register research in Norway.

8.6 Register research in Sweden.

8.7 Discussion.

9 An introduction to mental health services research(Anna Fernandez, Alejandra Pinto-Meza, Antoni Serrano-Blanco,Jordi Alonso and Josep Maria Haro).

9.1 Introduction.

9.2 What is mental health services research?

9.3 A framework for mental health services research.

9.4 Key concepts in mental health services research.

9.5 Examples of mental health services research studies.

9.6 Conclusion.

10 The pharmacoepidemiology of psychiatric medications(Philip S. Wang, Alan M. Brookhart, Christine Ulbricht andSebastian Schneeweiss).

10.1 Introduction.

10.2 Overview of psychopharmacoepidemiology.

10.3 Sources of data.

10.4 Examples of recent psychopharmacoepidemiologic studies.

10.5 Conclusions.

11 Peering into the future of psychiatric epidemiology(Michaeline Bresnahan, Ezra Susser, Dana March and BruceLink).

11.1 Introduction.

11.2 Levels of causation: A historical overview.

11.3 Levels of causation.

11.4 Causation over (life) time.

11.5 Examples.

11.6 Framing the future.

12 Studying the natural history of psychopathology(William W. Eaton).

12.1 Introduction.

12.2 Onset.

12.3 Course.

12.4 Outcome.

12.5 Methodological concepts for studying the natural history ofpsychopathology.

12.6 Conclusion.

13 Symptom scales and diagnostic schedules in adultpsychiatry (Jane M. Murphy).

13.1 Introduction.

13.2 North American instruments for epidemiologicalresearch.

13.3 North American instruments for psychiatric services andprimary care.

13.4 European instruments for psychiatric services and primarycare.

13.5 European instruments for epidemiological research.

13.6 Summary.

14 The National Comorbidity Survey (NCS) and itsextensions (Ronald C. Kessler).

14.1 Introduction.

14.2 The baseline NCS.

14.3 The NCS follow-up survey (NCS-2).

14.4 The NCS replication survey (NCS-R).

14.5 The NCS-R adolescent supplement (NCS-A).

14.6 The WHO WMH Surveys.

14.7 Overview.

15 Experimental epidemiology (John R. Geddes).

15.1 Introduction.

15.2 Limitations of non-randomised evidence.

15.3 RCTs: The translation of the experimental design into thereal world.

15.4 Importance and control of systematic error or bias.

15.5 Importance and control of random error and noise.

15.6 Reporting the results of clinical trials—the CONSORTstatement.

15.7 Different clinical questions will prioritise control ofdifferent threats to validity and confidence.

15.8 The classification of RCTs.

15.9 Effectiveness trials in schizophrenia.

15.10 Department of Veterans Affairs co-operative study on thecost-effectiveness of Olanzapine (Rosenheck).

15.11 The clinical antipsychotic trials of interventioneffectiveness (CATIE) study.

15.12 Cost utility of the latest antipsychotic drugs inschizophrenia study (CUtLASS 1).

15.13 European first-episode schizophrenia trial (EUFEST).

15.14 The size and cost of experimental studies inpsychiatry.

15.15 Clinical trials in the future.

16 Epidemiology of Schizophrenia (William W. Eaton,Chuan-Yu Chen and Evelyn J. Bromet).

16.1 Introduction.

16.2 Methods.

16.3 The burden of schizophrenia.

16.4 Natural history.

16.5 Demographic correlates.

16.6 Social risk factors.

16.7 Biological risk factors.

16.8 Prevention.

16.9 Discussion.

17 Epidemiology of depressive disorders (Deborah S.Hasin, Miriam C. Fenton and Myrna M. Weissman).

17.1 Introduction.

17.2 Major depression.

17.3 Dysthymia.

17.4 Summary.

18 Epidemiology of anxiety disorders (Ewald Horwath,Felicia Gould and Myrna M. Weissman).

18.1 Introduction.

18.2 Anxiety disorders.

18.3 Panic disorder.

18.4 Agoraphobia.

18.5 Social phobia.

18.6 Generalised anxiety disorder.

18.7 Obsessive–compulsive disorder.

18.8 Anxiety and affective disorders and mass disasters.

18.9 Future developments.

19 Epidemiology of bipolar disorder in adults andchildren (Kathleen R. Merikangas and MauricioTohen).

19.1 Introduction.

19.2 Epidemiology of bipolar disorder.

19.3 Patterns of comorbidity of bipolar disorder.

19.4 Risk Factors.

19.5 Future directions.

19.6 Summary.

20 Epidemiology of eating disorders (Tracey D. Wade,Anna Keski-Rahkonen and James I. Hudson).

20.1 Introduction.

20.2 Case definition.

20.3 Major prevalence studies.

20.4 Incidence studies.

20.5 Comorbidity.

20.6 Mortality from eating disorders.

20.7 Risk factors.

20.8 Future directions.

21 Epidemiology of alcohol use, abuse and dependence(Deborah A. Dawson, Ralph W. Hingson and Bridget F.Grant).

21.1 Introduction.

21.2 Population estimates of per capita consumption.

21.3 Survey-based estimates of the prevalence of drinking.

21.4 Alcohol-related mortality and morbidity.

21.5 Alcohol and injury.

21.6 Alcohol and chronic disease.

21.7 Diagnostic classification of alcohol use disorders.

21.8 Population estimates, prevalence, incidence and naturalcourse of alcohol use disorders.

21.9 Comorbidity of DSM-IV alcohol use disorders and otherpsychiatric disorders.

21.10 Summary.

22 Epidemiology of illicit drug use disorders (WilsonM. Compton, Marsha F. Lopez, Kevin P. Conway and Yonette F.Thomas).

22.1 Introduction.

22.2 Drug consumption.

22.3 Definitions.

22.4 Rates of DSM-IV abuse and dependence.

22.5 Global rates of drug use disorders.

22.6 Comorbidities with psychiatric conditions.

22.7 Genetic epidemiology.

22.8 Future opportunities.

22.9 Conclusions.

22.10 Disclaimer.

23 The epidemiology of personality disorders: Findings,methods and concepts (Michael J. Lyons, Beth A. Jerskey andMargo R. Genderson).

23.1 Introduction.

23.2 Substantive findings.

23.3 Course, prognosis and developmental issues.

23.4 Treated prevalence.

23.5 Prevalence of specific personality disorders.

23.6 Antisocial personality disorder.

23.7 Conceptual issues.

23.8 Models of personality disorder.

23.9 Methodological issues.

23.10 Future directions.

24 The epidemiology of depression and anxiety in children andadolescents (Kathleen Ries Merikangas and Erin F.Nakamura).

24.1 Introduction.

24.2 Magnitude of depression and anxiety in children andadolescents.

24.3 Correlates and risk factors.

24.4 Service patterns and impact.

24.5 Summary.

25 Epidemiology of attention deficit hyperactivitydisorder (Stephen V. Faraone).

25.1 Introduction.

25.2 Prevalence of ADHD.

25.3 Pharmacoeconomics of ADHD.

25.4 Comorbid psychiatric disorders.

25.5 Demographic risk factors.

25.6 Genetic risk factors.

25.7 Environmental risk factors for ADHD.

25.8 Summary and conclusions.

25.9 Future directions.

26 The epidemiology of autism (Gregory S.Liptak).

26.1 Introduction.

26.2 Background.

26.3 Definition and diagnosis.

26.4 Natural history.

26.5 Prevalence.

26.6 Risk factors.

26.7 Genetic factors.

26.8 Public health impact.

26.9 Associations and causal factors.

26.10 Future directions.

26.11 Summary.

27 Mental illness, women, mothers and their children(Kathryn M. Abel and Vera A. Morgan).

27.1 Introduction.

27.2 The epidemiology of mental illness in women of reproductiveage.

27.3 Fertility and fecundity in women with mental illness.

27.4 Maternal mental illness at the time of conception andduring pregnancy.

27.5 Gene–environment interactions and offspringoutcomes.

27.6 Obstetric complications and risk of adult onset mentaldisorder in offspring.

27.7 Parental condition.

27.8 Motherhood and perinatal mental illness.

27.9 Designing studies examining the relationship betweenmaternal mental illness and outcomes for their children.

27.10 Conclusions.

28 Epidemiology of suicide and attemptedsuicide(Dianne Currier and Maria A. Oquendo).

28.1 Introduction.

28.2 Definitions.

28.3 Prevalence of suicide and attempted suicide.

28.4 Risk factors for suicide and attempted suicide.

28.5 Protective factors.

28.6 Conclusions.

29 Epidemiology and geriatric psychiatry (Celia F.Hybels and Dan G. Blazer).

29.1 Introduction.

29.2 Issues of case identification.

29.3 The distribution of cases.

29.4 Aetiological studies.

29.5 Outcome studies.

29.6 Historical trends in the epidemiology of psychiatricdisorders in late life.

29.7 Use of health care services.

30 Recent epidemiological studies of psychiatricdisorders in Japan (Masayoshi Kawai, Kenji J. Tsuchiya andNori Takei).

30.1 Introduction.

30.2 Schizophrenia.

30.3 Affective disorders.

30.4 Autism and autism spectrum disorder.

30.5 Summary.

31 Epidemiology of migration and serious mental illness: Theexample of migrants to Europe (Monica Charalambides, CraigMorgan and Robin M. Murray).

31.1 Introduction.

31.2 Defining the constructs.

31.3 High rates of psychosis in migrants: A genuine finding ormethodological artefact?

31.4 Possible explanations.

31.5 Biological considerations.

31.6 Cannabis use.

31.7 Adverse social experiences.

31.8 Mechanisms.

31.9 Implications.

32 Epidemiology of migration substance use disorder in LatinAmerican populations and migration to the United States(María Elena Medina-Mora, Guilherme Borges, Tania Real andJorge Villatoro).

32.1 Introduction.

32.2 Definitions: What do we understand by migration?

32.3 Countries of origin: Social, political and other reasonsthat trigger migration.

32.4 Living conditions of migrants in the United States.

32.5 Alcohol and drug use in countries of origin and receivingcommunities.

32.6 Dependence and treatment rates.

32.7 The process of migrating.

32.8 Migration, substance use and access to services.

32.9 Returning migrants and families left behind.

32.10 Conclusions.

33 Early detection and intervention as approaches forpreventing schizophrenia (Ming T. Tsuang, William S. Stone,Margo Genderson and Michael Lyons).

33.1 Introduction.

33.2 Modelling genetic and phenotypic heterogeneity.

33.3 Defining a syndrome of liability using cognitive andclinical characteristics of relatives.

33.4 Gene-based vs. genome-based research.

33.5 Future directions.

33.6 Clinical implications.




Read More Show Less

Customer Reviews

Average Rating 1
( 1 )
Rating Distribution

5 Star


4 Star


3 Star


2 Star


1 Star


Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation


  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously
Sort by: Showing 1 Customer Reviews
  • Posted April 28, 2011

    $200 seriously?

    $200 for an ebook is ridiculious it's not even worth the paper it is printed on for that much and it is not even printed on paper it is an ebook for Gods sake!

    0 out of 1 people found this review helpful.

    Was this review helpful? Yes  No   Report this review
Sort by: Showing 1 Customer Reviews

If you find inappropriate content, please report it to Barnes & Noble
Why is this product inappropriate?
Comments (optional)